Investors want to invest in the right place and we are the right place. We have a very strong and persistent capability for innovation
In Conversation
With the new university and faculty leadership, attention has been turning from a traditionally strong basic research focus to a more innovation- and development-based programming
Over the last two years, the Czech Republic has achieved big advances in terms of patient advocacy, and we should influence other CEE countries in this…
To survive in Hungary we do not bring me-too products to market but instead, work to fill the gaps which exist
For patients suffering from genetic diseases in China, the frequent and chronic healthcare models that we see in the US and EU may not work
Our cumulative sales of biosimilars have reached EUR 140 million, and we are the market leader for infliximab, rituximab and trastuzumab biosimilar in the region.
While the level of generic penetration is still the same — it has barely changed in proportion to innovators— the price pressure, especially in generics, comes…
Today, we are the world’s second-largest pharma market. I hope that in a decade or two, China will also become the world’s second-most innovative pharma market
Pharma companies in the Czech Republic grow by double-digits every year. At first, they encounter many difficulties to access the market, but once they achieve that,…
Hurricane Maria was a turning point for us, it made Allied Logistics stronger. We literally moved Puerto Rico through the hurricane
It is important to have smart investors, willing to take a higher risk, who value factors such as know-how and Intellectual Property, and who are relatively…
Many people in the industry were worried about what would happen if all phase I studies disappeared from Sweden, and in retrospect, I have realized how…
